Sanofi ADR

NAS: SNY

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Sanofi ADR

After Hours

SNY
/zigman2/quotes/201967021/composite

$

47.03

Change

+0.0100 +0.02%

Volume

Volume 888

Dec 4, 2023, 4:08 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/201967021/composite

Today's close

$ 46.72

$ 47.02

Change

+0.30 +0.64%

Day low

Day high

$46.60

$47.15

Open
Open: 46.75

52 week low

52 week high

$42.63

$57.82

Open

Market cap

$116.79B

Average volume

2.25M

P/E ratio

13.18

Rev. per Employee

$494,994

EPS

3.57

Dividend

N/A

Div yield

2.92%

Ex dividend date

5/26/22

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/sny

MarketWatch News on SNY

  1. A Golden Age of Vaccines Is Here. What It Means for You.

    3:20 p.m. Nov. 21, 2023

    - Neal Templin

  3. Teva shares climb as third-quarter sales top estimates

    8:46 a.m. Nov. 8, 2023

    - Eleanor Laise

  4. Pharma Stocks Are Bleeding. 2 Look Like Bargains.

    10:51 a.m. Nov. 6, 2023

    - Josh Nathan-Kazis

  5. Moderna Reports Big Loss in Post-Pandemic Reset

    6:30 a.m. Nov. 2, 2023

    - Josh Nathan-Kazis

  7. GSK Raises Guidance on Strong Sales of Arexvy Vaccine

    10:55 a.m. Nov. 1, 2023

    - Josh Nathan-Kazis

  8. Drug Stocks Keep Tanking on Earnings. Brace for More.

    11:08 a.m. Oct. 30, 2023

    - Josh Nathan-Kazis

  9. MeiraGTx shares jump as Sanofi invests in gene therapy

    8:28 a.m. Oct. 30, 2023

    - Eleanor Laise

  10. Sanofi to Spin Out Consumer Health Division

    11:37 a.m. Oct. 27, 2023

    - Josh Nathan-Kazis

  13. Companies Push Forward With RSV Vaccine Amid Shortages

    12:02 p.m. Oct. 25, 2023

    - Josh Nathan-Kazis

  14. Stocks Poised to Open Higher

    6:35 p.m. Oct. 22, 2023

    - Janet H. Cho

  15. Big Tech Stocks, Boeing Earnings, GDP, and More

    2:00 p.m. Oct. 22, 2023

    - Nicholas Jasinski

  17. Moderna Says Flu-Covid Vaccine Succeeds in Early-Stage Trial

    10:34 a.m. Oct. 4, 2023

    - Josh Nathan-Kazis

  19. Pfizer maternal RSV vaccine recommended by CDC

    5:24 p.m. Sept. 22, 2023

    - Eleanor Laise

  20. Pfizer maternal RSV vaccine recommended by CDC advisors

    2:58 p.m. Sept. 22, 2023

    - Eleanor Laise

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/sny

Other News on SNY

  1. Why Covid Lockdowns and Mask Mandates Made Children Sicker

    1:30 p.m. Nov. 27, 2023

    - The Wall Street Journal Interactive Edition

  2. Bayer Mulls Possible Split of Crops or Consumer Health

    5:34 a.m. Nov. 8, 2023

    - The Wall Street Journal Interactive Edition

  3. When to Get Your Covid-19, Flu and RSV Shots This Fall

    2:10 p.m. Nov. 1, 2023

    - The Wall Street Journal Interactive Edition

  4. Why Drug Companies Don’t Want to Sell Allergy Medicines and Bandages Anymore

    1:48 a.m. Oct. 30, 2023

    - The Wall Street Journal Interactive Edition

  5. New RSV Drug Has Limited Supply, CDC Says

    1:34 a.m. Oct. 25, 2023

    - The Wall Street Journal Interactive Edition

  6. This $5 Billion Biotech Home Run Took Less Than a Year

    1:33 a.m. Oct. 25, 2023

    - The Wall Street Journal Interactive Edition

  7. Pro Take: Making Medicines Greener

    3:27 a.m. Oct. 25, 2023

    - The Wall Street Journal Interactive Edition

  8. Sanofi Faces Third-Quarter Forex Hit

    2:05 a.m. Sept. 22, 2023

    - The Wall Street Journal Interactive Edition

  9. J&J Revamps Drug Research, Plots Medical Device Deals

    1:32 a.m. Sept. 15, 2023

    - The Wall Street Journal Interactive Edition

  10. FDA Approves RSV Vaccine to Pass Protection From Mother to Child

    1:33 a.m. Aug. 22, 2023

    - The Wall Street Journal Interactive Edition

  11. Venture Capitalist Seeks to Spur Drug Development for Rare Autoimmune Disease

    1:32 a.m. Aug. 2, 2023

    - The Wall Street Journal Interactive Edition

  12. Biogen’s New Boss Is Delivering, but Stock Isn’t Pricing It in Yet

    1:33 a.m. Aug. 1, 2023

    - The Wall Street Journal Interactive Edition

  13. FDA Approves First RSV Drug to Protect All Infants

    1:32 p.m. July 18, 2023

    - The Wall Street Journal Interactive Edition

  14. Sanofi Wins Supreme Court Patent Dispute With Amgen

    1:33 a.m. May 19, 2023

    - The Wall Street Journal Interactive Edition

  15. J&J Prices Consumer Unit IPO at $22 a Share

    1:33 a.m. May 4, 2023

    - The Wall Street Journal Interactive Edition

  16. FDA Approves GSK’s RSV Vaccine for Older Adults

    1:34 a.m. May 4, 2023

    - The Wall Street Journal Interactive Edition

  17. J&J Consumer-Health Unit’s Listing to Test IPO Market

    2:35 a.m. April 24, 2023

    - The Wall Street Journal Interactive Edition

  18. Gavin Newsom, Insulin CEO

    1:33 a.m. March 31, 2023

    - The Wall Street Journal Interactive Edition

  19. Amgen Seeks to Monopolize Nature

    4:53 p.m. March 26, 2023

    - The Wall Street Journal Interactive Edition

  20. Regeneron, Sanofi Look for Billions From COPD Drug

    2:50 p.m. June 2, 2023

    - The Wall Street Journal Interactive Edition

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.